Evidence map›Paper›PMID 39858455›Full record

ArticleBiomolecules2025

Synthesis and Antifungal Activity of Fmoc-Protected 1,2,4-Triazolyl-α-Amino Acids and Their Dipeptides Against

Tatevik Sargsyan, Lala Stepanyan, Henrik Panosyan, Heghine Hakobyan, Monika Israyelyan, Avetis Tsaturyan, Nelli Hovhannisyan, Caterina Vicidomini, Anna Mkrtchyan, Ashot Saghyan and 1 more

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Sequential soxhlet fractionation ofFrontiers in chemistry · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tatevik SargsyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Lala StepanyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Henrik PanosyanScientific Technological Center of Organic and Pharmaceutical Chemistry, 26, Azatutian Ave., Yerevan 0014, Armenia.ORCID 0000-0001-8311-6276
Heghine HakobyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Monika IsrayelyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Avetis TsaturyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.ORCID 0000-0001-9716-7744
Nelli HovhannisyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Caterina VicidominiInstitute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy.
Anna MkrtchyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.ORCID 0000-0003-0325-1799
Ashot SaghyanScientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan Str., Yerevan 0056, Armenia.
Giovanni N RovielloInstitute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy.ORCID 0000-0002-6978-542X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, fungal infections have emerged as a significant health concern across veterinary species, especially in livestock such as cattle, where fungal diseases can result in considerable economic losses, as well as in humans. In particular,

Indexed as

Amino AcidsAntifungal AgentsAspergillusDipeptidesTriazolesAnimalsMicrobial Sensitivity TestsStructure-Activity RelationshipAmino AcidsAntifungal AgentsDipeptidesTriazoles1,2,4-triazolesAlternaria alternateantifungal peptidesAspergillus candidusAspergillus flavusAspergillus versicolorAureobasidium pullulansdipeptidesfluconazolenon-protein amino acidssynthesisUlocladium botrytis

Identifiers

PMID39858455
PMCPMC11762334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.